Showing results (381-390 of 773) with videos related to
Sort By:
Pageof 78
ATS Scholar|August 19, 2021
Impact of Risk and Volume on Procedural Traning of Pulmonary and Critical Care FellowsJeremy B Richards, Dru Claar, Michael T McCurdy, et al.Cureus|October 13, 2022
Identifying Recurrence Risk Factors in CT-Confirmed Acute Appendicitis in Adults Managed Non-operatively During the COVID-19 PandemicChris B Richards, Laura K Pendower, Pinky D Kotecha, et al.Cancer Research|July 9, 1999
Apoptosis induced by overexpression of hMSH2 or hMLH1H Zhang, B Richards, T Wilson, et al.European Urology|January 1, 1995
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostateM R Robinson, P H Smith, B Richards, et al.Veterinary Microbiology|January 1, 1991
Characterisation of virulent and benign strains of Bacteroides nodosusL J Depiazzi, R B Richards, J Henderson, et al.Kidney International|December 12, 2001
Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristaneH B Richards, M Satoh, J C Jennette, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupusNicola Calvani, Roberto Caricchio, Marco Tucci, et al.Journal of the American Board of Family Medicine : JABFM|June 5, 2021
Multilevel Small Area Estimation of Prostate-Specific Antigen Screening Test in the United States by Age Group: 2018 Behavioral Risk Factor Surveillance SystemZahava Berkowitz, Xingyou Zhang, Thomas B Richards, et al.Kidney International|February 9, 2005
Circulating endothelial cells are associated with future vascular events in hemodialysis patientsMehmet Koc, Hanno B Richards, Azra Bihorac, et al.The Journal of Urology|December 1, 1977
Intravesical epodyl in the management of bladder tumors: combined experience of the Yorkshire Urological Cancer Research GroupM R Robinson, M B Shetty, B Richards, et al.Pageof 78